Hyperemesis gravidarum: Difference between revisions

No edit summary
Line 36: Line 36:
A Randomized Controlled Trial”
A Randomized Controlled Trial”
http://www.ncbi.nlm.nih.gov/pubmed/24807340</ref>
http://www.ncbi.nlm.nih.gov/pubmed/24807340</ref>
***If using ondansetron, have a discussion about claimed risks of birth defects, and document this due to arising class action lawsuits
***Ondansetron is still class B (no proven risk to humans)
**[[Promethazine]] 25-50mg IV q4hr
**[[Promethazine]] 25-50mg IV q4hr
*Alternative Medications
*Alternative Medications

Revision as of 16:34, 31 March 2015

Background

  • Simple nausea and vomiting affects 60-80% of pts during first 12wk of pregnancy
  • Hyperemesis gravidarum defined as intractable vomiting with at least 1 of following:

Clinical Features

  • Signs of volume depletion
  • Abdominal pain is highly unusual and if present suggests a different diagnosis

Work-Up

  1. CBC
  2. Chemistry
  3. UA

DDx

Treatment

  • IVF (use fluid containing 5% glucose to reverse ketonuria)
  • Antiemetics
    • Ondansetron 8mg IV or 4mg PO TID[1]
      • If using ondansetron, have a discussion about claimed risks of birth defects, and document this due to arising class action lawsuits
      • Ondansetron is still class B (no proven risk to humans)
    • Promethazine 25-50mg IV q4hr
  • Alternative Medications
    • Ginger 1-1.5g PO divided BID-QID
    • Doxylamine succinate + pyridoxine hydrochloride (Diclegis)
    • Antihistamines (1st line tx Diphenhydramine, Meclizine, Dimenhydrinate)

Disposition

  1. Discharge if ketonuria reversed and pt able to tolerate PO
  2. Admit if:
    1. Uncertain diagnosis
    2. Intractable vomiting
    3. Persistent ketone or electrolyte abnormalities after volume repletion
    4. Wt loss >10% of prepregnancy weight

Source

Tintinalli

  1. “Ondansetron Compared With Metoclopramide for Hyperemesis Gravidarum A Randomized Controlled Trial” http://www.ncbi.nlm.nih.gov/pubmed/24807340